Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
OPERATING ACTIVITIES    
Net loss $ (1,095) $ (20,707)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Provision for doubtful accounts 6,104 5,641
Depreciation 6,659 6,963
Loss on disposal of medical equipment 434 207
Gain on sale of medical equipment (1,340) (1,662)
Amortization of intangibles 4,649 5,560
Asset impairment charges 993
Amortization of deferred debt issuance costs 33 28
Stock-based compensation expense 957 682
Deferred income tax benefit (expense) (62) 15,389
Changes in Assets - (Increase)/Decrease:    
Accounts receivable (4,413) (5,344)
Inventories (490) 402
Other current assets (222) (201)
Other assets (6) 119
Changes in Liabilities - Increase/(Decrease):    
Accounts payable and other liabilities 183 (352)
NET CASH PROVIDED BY OPERATING ACTIVITIES 11,391 7,718
INVESTING ACTIVITIES    
Purchases of medical equipment (8,022) (2,652)
Purchases of property and equipment (281) (104)
Purchases of intangible assets (192)
Proceeds from sale of medical equipment 3,319 3,866
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES (4,984) 918
FINANCING ACTIVITIES    
Principal payments on term loans and capital lease obligations (6,319) (37,466)
Cash proceeds from bank loans and revolving credit facility 11,162 28,866
Debt Issuance Costs (27) (38)
Cash Proceeds - Stock Plans 91 131
Common stock repurchased as part of Repurchase Program (10,395)
Common stock repurchased to satisfy taxes on stock based compensation (70) (58)
NET CASH USED IN FINANCING ACTIVITIES (5,558) (8,565)
Net change in cash and cash equivalents 849 71
Cash and cash equivalents, beginning of year 3,469 3,398
Cash and cash equivalents, end of year 4,318 3,469
SUPPLEMENTAL DISCLOSURES    
Cash paid for interest 1,383 1,200
Cash paid for income taxes 159 139
NON-CASH TRANSACTIONS    
Additions to medical equipment and property [1] 998 549
Medical equipment acquired pursuant to a capital lease $ 137
[1] Amounts consist of current liabilities for medical equipment that have not been included in investing activities. These amounts have not been paid for as of December 31, 2018 and 2017, respectively, but will be included as a cash outflow from investing activities for purchases of medical equipment and property when paid.